Israeli biotech firm Biond Biologics lands $17 mln Series B
Biond Biologics Ltd, an Israeli biotechnology company, has secured $17 million in Series B financing. Israel Biotech Fund and Harel Insurance & Finance Group led the round with participation from other investors that included Celgene Corporation and SBI JI Innovation Fund.
8 January 2019•1 min read
